Lirimilast
Lirimilast (BAY 19-8004; BAY 198004) is a potent and selective PDE4 inhibitor for the treatment of COPD.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
443.251
Molecular Formula
C17H12Cl2N2O6S
Notes
Research use only, not for human use.
Receptor
PDE
CAS Number
329306-27-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1073829-01 0.02 mg (E-Coli)
Recombinant Androctonus australis Potassium channel toxin alpha-KTx 3.5 (KTX2)
Ask
View Details 
MBS1073829-02 0.1 mg (E-Coli)
Recombinant Androctonus australis Potassium channel toxin alpha-KTx 3.5 (KTX2)
Ask
View Details MBS1073829-03 0.02 mg (Yeast)
Recombinant Androctonus australis Potassium channel toxin alpha-KTx 3.5 (KTX2)
Ask
View Details MBS1073829-04 0.1 mg (Yeast)
Recombinant Androctonus australis Potassium channel toxin alpha-KTx 3.5 (KTX2)
Ask
View Details